Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Low-Cost, Scalable Treatment Strategy for Improving Hypertension Control in Low and Middle-Income Settings: Formative Phase (Aim 1)

NCT07784647 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT07784647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07784647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Low-Cost, Scalable Treatment Strategy for Improving Hypertension Control in Low and Middle-Income Settings: Formative Phase (Aim 1)
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Completed
Start date
April 1, 2026
Completion date
August 7, 2026
Enrollment
1,444 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

health services accessibility, hypertension